Search CROs

• Computational & In-Silico Drug Discovery
• Discovery Research
• High-Throughput Screening

Integrated CRO-CDMO with 25+ years of discovery and development expertise across small and large molecules, operating 16 US FDA-inspected cGMP facilities across three manufacturing countries.

• Bioanalysis
• In Vivo PK / PD Studies
• LC-MS Bioanalysis (Small Molecule)

GLP-compliant bioanalytical CRO specializing in LC-MS/MS solutions for preclinical and clinical research, IND submissions, and new drug applications.

• Analytical Method Development & Validation
• Bioanalysis
• Microbiology Services

Full-service CRO delivering analytical, bioanalytical, and microbiology services across small molecules, biologics, gene therapy, and botanical drugs from discovery through clinical development.

• Analytical Method Development & Validation
• Medicinal Chemistry
• Regulatory Affairs

Canadian CRO and CDMO specializing in polymer synthesis, peptide characterization, and advanced analytical services for drug delivery and pharmaceutical development. FDA-registered and ISO 9001:2015 certified, serving North American pharmaceutical and biotech companies.

• Discovery Research
• In Vivo Efficacy Models
• Preclinical In Vitro Studies

Cyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical research, with specialized expertise in humanized mice, gene therapy vectors, and disease-specific models across oncology, neurology, and metabolic disorders.

• Analytical Method Development & Validation
• Regulatory Affairs
• Translational Research

Leading CRO/CDMO provider specializing in viral vectors, proteins, and vaccines with proprietary AAV manufacturing technology and cGMP-grade facilities operational since October 2023.

• Bioanalysis
• Device & Combination Product Services
• GLP Toxicology

San Diego-based preclinical CRO specializing in GLP toxicology, in vivo pharmacology, custom animal models, and medical device testing across rodent to non-human primate species.

• Bioanalysis
• Carcinogenicity Studies
• Flow Cytometry Services

Midsize preclinical CRO specializing in GLP-compliant toxicology, IND-enabling safety studies, infectious disease vaccine development, and inhalation toxicology with onsite integrated laboratories and 60+ years of regulatory partnership experience.

• Antibody-Drug Conjugate (ADC)
• Biologics (Monoclonal Antibodies)
• Biologics (Other)

Fully integrated biologics and bioconjugates CDMO+CRO offering drug design, development, and GMP manufacturing for antibodies, ADCs, AOCs, RDCs, and vaccines from discovery through commercial scale.

• In Vitro Pharmacology
• In Vivo Efficacy Models
• In Vivo PK / PD Studies

GemPharmatech develops and supplies genetically engineered mouse models (GEMMs) and preclinical research services using CRISPR/Cas9 and gene-editing technologies, with a library of 25,000+ mouse strains including KO/cKO, humanized, and immunodeficient models.

• Genetic Toxicology
• GLP Toxicology
• In Vitro ADME / DMPK

GLP-compliant nonclinical CRO specializing in safety and toxicology testing across in silico, in vitro, and in vivo modalities, with 35+ years of experience and nearly 6,000 completed studies.

• Analytical Method Development & Validation
• Bioanalysis
• Discovery Research

Advanced preclinical CRO providing comprehensive drug and device development services including bioanalysis, GLP toxicology, pharmacodynamic modeling, and specialized testing for oncology, infectious disease, gene therapy, and synthetic biology programs.

• DART (Reproductive & Developmental Toxicology)
• GLP Toxicology
• In Vivo Efficacy Models

Europe-based preclinical CRO specializing in GLP-compliant toxicology, safety assessment, and efficacy testing for small molecules and biologics, with AAALAC accreditation and integrated translational research capabilities.

• Analytical Method Development & Validation
• Bioanalysis
• Genetic Toxicology

Canada's largest privately owned CRO specializing in GMP and GLP testing for pharmaceutical, biologic, and medical device companies. Offers analytical chemistry, microbiology, toxicology, bioanalytical, and genetic toxicology services with over 50 years of experience.

• Biomarker Assays
• Genomics & Sequencing Services
• Immunology & Inflammation Services

Oncology-focused preclinical CRO with AAALAC-accredited China-based labs offering 2300+ PDX models, MiniPDX organoid assays, and multi-omics analysis for drug discovery and development.

Preclinical CRO providing integrated research services including efficacy testing, disease model development, PK/PD, toxicology, biomarker research, and safety assessment across respiratory, ophthalmology, cardiovascular, and neurology therapeutic areas.

• GLP Toxicology
• High-Throughput Screening
• In Vitro ADME / DMPK

Creative Bioarray provides preclinical research solutions including drug screening, ADME-PK, toxicity studies, and cell-based services across oncology, neurology, cardiovascular, and metabolic therapeutic areas.

• Computational & In-Silico Drug Discovery
• Discovery Research
• GLP Toxicology

ChemDiv is a fully integrated target-to-clinic CRO headquartered in San Diego, CA, offering drug discovery services including medicinal chemistry, CADD, ADME/DMPK, toxicology, and custom synthesis alongside the industry's largest commercial screening library of 1.6M compounds.